Jump Financial’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
+2,317
New +$151K ﹤0.01% 1772
2026
Q1
Sell
-16,707
Closed -$530K 2410
2025
Q4
$530K Buy
+16,707
New +$521K 0.01% 1297
2025
Q1
Sell
-10,760
Closed -$500K 2033
2024
Q4
$500K Sell
10,760
-50,793
-83% -$2.3M 0.01% 1075
2024
Q3
$2.78M Buy
+61,553
New +$2.93M 0.06% 397
2024
Q2
Sell
-10,332
Closed -$354K 2280
2024
Q1
$354K Buy
+10,332
New +$373K 0.01% 1369
2023
Q4
Sell
-15,959
Closed -$323K 2262
2023
Q3
$323K Buy
+15,959
New +$351K 0.01% 1261
2023
Q2
Sell
-122,493
Closed -$1.85M 2167
2023
Q1
$1.85M Buy
122,493
+80,270
+190% +$1.77M 0.08% 386
2022
Q4
$1.01M Buy
42,223
+34,832
+471% +$1.01M 0.05% 485
2022
Q3
$260K Buy
+7,391
New +$314K 0.01% 1220
2022
Q1
Sell
-3,910
Closed -$303K 1922
2021
Q4
$303K Sell
3,910
-2,590
-40% -$266K 0.02% 891
2021
Q3
$695K Buy
+6,500
New +$744K 0.05% 391

Other funds holding TWST

Jump Financial's TWST Position: Q2 2026 in Review

Jump Financial opened a new position in Twist Bioscience (TWST) in Q2 2026: 2,317 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #1772 among its holdings. This is a return to the name: Jump Financial previously reported a position in TWST as recently as Q4 2025.

Jump Financial first reported a position in TWST in Q3 2021 and has held it in 11 quarters since. The position peaked at $2.78M in Q3 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Jump Financial held 2,317 shares of Twist Bioscience worth $238K as of Q2 2026.
  • Twist Bioscience was a new Jump Financial position in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1772 holding.
  • Jump Financial first reported a position in Twist Bioscience in Q3 2021 and has held it in 11 quarters since.
  • Jump Financial's Twist Bioscience position peaked at $2.78M in Q3 2024.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.